Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

HealthRX vs LifeRx.md

HealthRX
Graded #8

Higher grade

vs+16.799999999999997
LifeRx.md
Graded #127

Lower grade

The verdict

HealthRX takes it — 86.1/100 to 69.3/100.

HealthRX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A LegitScript-certified (#50087439) physician-supervised program that runs a rare oral GLP tablet alongside the usual injectables — compounded semaglutide from ~$189/mo, tirzepatide/GLP+GIP up to ~$349, with a brand Ozempic pass-through if you need it.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueHealthRX +28
85
57
Dose & formulationHealthRX +18
90
72
Clinical oversightHealthRX +1
87
86
Labs & monitoringHealthRX +20
82
62
FulfillmentHealthRX +5
86
81
Contract termsHealthRX +30
85
55
HealthRX · left barLifeRx.md · right bar

The numbers

MetricHealthRXLifeRx.md
WeighScore86.1/10069.3/100
GradeBC
Scorecard rank#8#127
Semaglutide$189/mo$200/mo
Tirzepatide$349/mo$275/mo
CoverageNot publicly listedAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
HealthRX

Graded #8 · B

Strengths

  • LegitScript-certified (#50087439) — a genuine, verifiable trust signal
  • Physician-supervised intake with licensed providers
  • Both molecules plus a rare oral GLP tablet option
  • Transparent flat monthly pricing, no insurance required

Where it loses points

  • Compounded semaglutide/tirzepatide is not FDA-approved
  • Some tiers are company-stated and the public site is thin
  • Brand Ozempic is a steep pass-through (~$1,299)
  • State count is not publicly listed
LifeRx.md

Graded #127 · C

Strengths

  • Flat pricing that does not rise with dose: semaglutide ~$200, tirzepatide ~$275 per 5-week supply
  • LegitScript certified; prescriptions filled by state-licensed 503A pharmacies
  • Available in all 50 states
  • HSA and FSA payments accepted
  • Required video telehealth consult ensures clinician oversight

Where it loses points

  • Compounded GLP-1s are not FDA-approved for safety, efficacy or quality
  • Extra fees stack up: ~$30 shipping, $49.95 initial consult, $25 follow-ups
  • True monthly cost (~$255) is higher than the headline medication price
  • Specific list of supported states not enumerated on site

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard